Idera Pharmaceuticals, Inc.
Symbol: IDRA
NASDAQ
0.425
USDMarket price today
-97.1145
P/E Ratio
7.8442
PEG Ratio
26.50M
MRK Cap
- 0.00%
DIV Yield
Idera Pharmaceuticals, Inc. (IDRA) Stock Price & Analysis
Shares Outstanding
0M
Gross Profit Margin
58.88%
Operating Profit Margin
680.24%
Net Profit Margin
665.27%
Return on Assets
-0.42%
Return on Equity
-1.90%
Return on Capital Employed
-0.55%
Company general description and statistics
General Outlook
Return on Investments
Stock Prices
Liquidity Ratios
Analyzing IDRA liquidity ratios reveals its financial health of the firm. The current ratio of 31.55% gauges short-term asset coverage for liabilities. The quick ratio (24.19%) assesses immediate liquidity, while the cash ratio (11.86%) indicates cash reserves.
cards.indicator | cards.value |
Current Ratio | 31.55% |
Quick Ratio | 24.19% |
Cash Ratio | 11.86% |
Profitability Ratios
IDRA profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 67744.90% underscores its earnings before tax deductions. The effective tax rate stands at 1.80%, revealing its tax efficiency. The net income per EBT, 98.20%, and the EBT per EBIT, 99.59%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 68024.49%, we grasp its operational profitability.
cards.indicator | cards.value |
Pretax Profit Margin | 67744.90% |
Effective Tax Rate | 1.80% |
Net Income per EBT | 98.20% |
EBT per EBIT | 99.59% |
EBIT per Revenue | 68024.49% |
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 0.32, it details the span from stock purchase to revenue.
cards.indicator | cards.value |
Days of Sales Outstanding | 24 |
Operating Cycle | -16410.10 |
Days of Payables Outstanding | 439 |
Cash Conversion Cycle | -16849 |
Receivables Turnover | -0.02 |
Payables Turnover | 0.83 |
Fixed Asset Turnover | -0.10 |
Cash Flow Ratios
Lastly, the operating cash flow sales ratio, 470.53, offers insight into cash flow relative to sales.
cards.indicator | cards.value |
Operating Cash Flow Sales Ratio | 470.53 |
Free Cash Flow to Operating Cash Flow Ratio | 1.00 |
Cash Flow Coverage Ratio | -46.67 |
Short Term Coverage Ratio | -103.39 |
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.63%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.02, we discern the balance between debt and equity financing. The long-term debt to capitalization, 1.19%, and total debt to capitalization, 2.14%, ratios shed light on its capital structure. An interest coverage of 243.30 indicates its ability to manage interest expenses.
cards.indicator | cards.value |
Debt Ratio | 0.63% |
Debt Equity Ratio | 0.02 |
Long Term Debt to Capitalization | 1.19% |
Total Debt to Capitalization | 2.14% |
Interest Coverage | 243.30 |
Cash Flow to Debt Ratio | -46.67 |
Company Equity Multiplier | 3.48 |
Per Share Data
Net income per share, -7.18, reflects the portion of profit attributed to each share. The book value per share, 3.63, represents the net asset value distributed per share, while the tangible book value per share, -13.44, excludes intangible assets.
cards.indicator | cards.value |
Net Income Per Share | -7.18 |
Book Value Per Share | 3.63 |
Tangible Book Value Per Share | -13.44 |
Shareholders Equity Per Share | 3.63 |
Interest Debt Per Share | 0.23 |
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -10,344,523.2, captures the company's total value, considering both debt and equity. Income quality, 1.05, assesses the reliability of reported earnings.
cards.indicator | cards.value |
Enterprise Value | -10,344,523.2 |
Income Quality | 1.05 |
Intangibles to Total Assets | 81.79% |
Graham Number | 24.22 |
Return on Tangible Assets | -126.91% |
Graham Net Net | -14.43 |
Working Capital | -3,560,000 |
Tangible Asset Value | -43,766,000 |
Net Current Asset Value | -44,310,000 |
Average Receivables | 2,104,000 |
Average Payables | 2,882,500 |
ROIC | -187.30% |
ROE | -1.98% |
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 140.40, and the price to book ratio, 140.40, reflect the market's valuation relative to the company's book value.
cards.indicator | cards.value |
Price Book Value Ratio | 140.40 |
Price to Book Ratio | 140.40 |
Price Cash Flow Ratio | -137.31 |
Price Earnings to Growth Ratio | 7.84 |
Enterprise Value Multiple | -0.05 |
Price Fair Value | 140.40 |
Price to Operating Cash Flow Ratio | -137.31 |
Price to Tangible Book Ratio | 0.10 |
Enterprise Value Over EBITDA | 0.37 |
EV to Operating Cash Flow | 0.42 |
Earnings Yield | -2050.06% |
Free Cash Flow Yield | -2149.67% |
Frequently Asked Question
How many company shares are outstanding in 2024?
There are stock number shares outstanding of Idera Pharmaceuticals, Inc. (IDRA) on the NASDAQ in 2024.
What is P/E ratio of enterprise in 2024?
The current P/E ratio of enterprise is -97.115 in 2024.
What is the ticker symbol of Idera Pharmaceuticals, Inc. stock?
The ticker symbol of Idera Pharmaceuticals, Inc. stock is IDRA.
What is company IPO date?
IPO date of Idera Pharmaceuticals, Inc. is 1996-01-25.
What is company current share price?
Current share price is 0.425 USD.
What is stock market cap today?
The market cap of stock today is 26501046.000.
What is PEG ratio in 2024?
The current 7.844 is 7.844 in 2024.
What is the number of employees in 2024?
In 2024 the company has 13.